• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    F

    First Pavlov State Medical University of St. Petersburg

    院校EST. 18971spbgmu.ru
    3,495论文总数
    3.4万引用总数

    The First Pavlov State Medical University of St. Petersburg (Russian: Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова, ПСПбГМУ им. акад. И. П. Павлова) is a higher education institution, medical university in St. Petersburg.[citation needed]PSPbGMU is called the First Medical Institute in St. Petersburg because of its renaming in 1936, relative to Saint Petersburg State Medical Academy named after I.I. Mechnikov, which is called the Second Medical Institute.

    论文量&引用量时间轴

    机构学者

    论文(3495)

    年份
    起
    –
    止
    排序
    1[Experimental Study of Radiation Sterilization and Degradation of Polylactide and Copolymer Membranes for Maxillofacial Surgery].
    A P Reutova, M A Markova, Zh B Lyutova, A V Popugaev, E A Zernitskaya, A I Yaremenko

    OBJECTIVE:The aim of the study. To evaluate the physicochemical properties and radiation stability of biodegradable membranes based on polylactic acid (PLA) and its copolymers (PLGA) for potential use in guided bone regeneration (GBR) in maxillofacial surgery. MATERIALS AND METHODS:Membranes made of pure PLA, PLA with hydroxyapatite (PLA/HAP), and polylactic-co-glycolic acid (PLGA) in 85:15 and 60:40 ratios were studied. Samples were sterilized using electron beam irradiation at a dose of 25 kGy. Degradation was carried out in phosphate-buffered saline at 37 °C. Molecular structure was assessed by FTIR spectroscopy, and surface morphology was evaluated using scanning electron microscopy (SEM). RESULTS:After one month, PLGA 60:40 samples lost approximately 40% of their mass and structural integrity and were excluded from further observation. PLGA 85:15 samples maintained shape and exhibited a minor mass loss (~5%). Non-irradiated PLA/HAP composites showed variable mass loss (0-19%), while irradiated ones displayed minimal changes (up to 2%). Pure PLA samples remained the most stable throughout the 2.5-month observation period, showing only minor hydrolytic surface alterations. Radiation sterilization did not cause significant changes in the molecular structure of any tested materials. CONCLUSION:PLA copolymers demonstrated controlled degradation rates and sufficient structural stability, making them promising candidates for the development of patient-specific resorbable membranes for GBR. Their predictable resorption profile may eliminate the need for secondary surgery to remove the membrane. The results support the feasibility of using ionizing radiation for sterilization without compromising material properties.

    2026Stomatologiia(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Efficacy and Safety of Four-Year Divozilimab Treatment in Relapsing Multiple Sclerosis (RMS)
    Aleksey Boyko, Olga Boyko, Yulia Linkova,Arina Zinkina-Orikhan, Marina Krasnova, Anna Eremeeva, Maria Ivanova, Anastasiya Porozova, Stella Sivertseva, Maria Zakharova, Daria Eliseeva,Natalia Totolyan,

    Background/Objective(s) In a phase III clinical trial (MIRANTIBUS), divozilimab (DIV) has demonstrated efficacy in significantly reducing annualized relapse rate (ARR) and MRI activity compared with teriflunomide along with favorable safety profile for up to 2 years in patients with relapsing multiple sclerosis (RMS). BCD-132 EXT was aimed to assess long-term efficacy and safety of divozilimab in patients with RMS. Material(s) and Method(s) BCD-132-EXT (NCT06987851) enrolled patients with RMS who had been previously treated with divozilimab at a dose of 500 mg Q6M in phase II BCD-132-2 (NCT04056897) and phase IIIBCD-132-4/MIRANTIBUS (NCT05385744) trials. Total treatment duration was 4 years. The efficacy assessment included ARR, MRI endpoints (T1 Gd+ lesions per scan, combined unique active lesions (CUA) per scan), and 6-month confirmed disability progression (CDP). Safety monitoring included evaluation of standard laboratory parameters and reporting of adverse events. Result(s) 44 patients were enrolled in BCD-132-EXT, 93.2% (41/44) completed 4 years of follow-up. In patients continuously treated with divozilimab ARR remained constantly low, with the overall ARR over 4 years of therapy being 0.052 (95% CI: 0.028; 0.097). Adjusted numbers of T1Gd+ lesions and CUA per scan during the treatment period were 0.011 (95% CI 0.004; 0.035) and 0.018 (0.006; 0.052), respectively. Cumulative probability of 6-month CDP rate was 4.5%. Adverse reactions were reported in 59.1% (26/44) of patients, most of which were mild to moderate. The most frequent adverse reactions were leukopenia, lymphopenia, neutropenia and infusion reactions. No serious adverse events were registered in study population. No new safety signals were identified. Conclusion(s) A favorable divozilimab long-term efficacy/safety profile for patients with relapsing MS was demonstrated in BCD-132-EXT.

    2026Multiple Sclerosis and Related Disorders(2026)
    引用
    AI阅读
    加入学术空间
    3Predicting Chronic Placental Insufficiency in Patients with a Complicated Obstetric History at Pregnancy Planning Stage
    D. R. Eremeeva, M. S. Zainulina

    Introduction. Chronic placental insufficiency (CPI) is one of the leading causes of fetal growth restriction (FGR), perinatal loss, and complicated pregnancy. Currently, no validated methods for predicting CPI during pregnancy planning are available, which complicates high-risk patient stratification early and enabling timely prevention. Aim: to develop a mathematical model for predicting CPI risk in women with a complicated obstetric history at the pre-pregnancy preparation stage. Materials and Methods . A retrospective clinical study assessing 462 patients with a complicated obstetric history was conducted. The outcomes of previous pregnancies, concomitant extragenital diseases, circulation of criterial (anti-β2glycoprotein and anti-cardiolipin antibodies, lupus anticoagulant) and non-criterial (anti-annexin 5, anti-phosphatidylserine, anti-phosphatidylinositol, anti-prothrombin, anti-human chorionic gonadotropin) antiphospholipid antibodies (APA), indicators of lymphocyte subpopulation composition, coagulation profile, and genetic thrombophilia were evaluated. Enzyme-linked immunosorbent assay, flow cytometry, ultrasound, and histological diagnostics were used. Binary logistic regression was applied to construct a prognostic model, and the diagnostic significance of the indicators was assessed using ROC curves. Results. Detected APA high titers and/or lupus anticoagulant were associated with significantly elevated CPI incidence (63.1% vs. 4.6%; p < 0.001) and FGR (43.4% vs. 4.6%; p < 0.001). Immunological imbalance (increased percentage of B-lymphocytes and NK cells) increased CPI risk by 1.3–5.5 times. The constructed prediction model, which included indicators of immunological activity and comorbidity, demonstrated high accuracy: AUC = 0.89, sensitivity 85.7%, specificity 85.7%. Conclusion. The developed mathematical model allows for highly accurate prediction of CPI risk developing in women with a complicated obstetric history even before pregnancy, which opens up avenues for personalized selection of preventive measures, including immunomodulatory therapy and dynamic monitoring, and contributes to lowering frequency of perinatal complications.

    2026Акушерство, гинекология и репродукция(2026)
    引用
    AI阅读
    加入学术空间
    4Adverse Events Associated with Genetically Engineered Biological Agents in Patients with Severe Bronchial Asthma: Experience in St. Petersburg
    O.N. Titova, N.A. Kuzubova, D.B. Sklyarova, Y.A. Afanasyeva

    Bronchial asthma (BA) remains a major global health challenge associated with high morbidity, mortality, and a considerable economic burden. Severe asthma is diagnosed in 5–10% of patients. These individuals often struggle to achieve adequate disease control despite high-dose inhaled corticosteroids and frequently require oral corticosteroids. The advent of biological therapy has represented a major breakthrough in the management of severe asthma. Modern highly selective agents that target key mediators of the inflammatory cascade now enable optimal disease control to be achieved. The monoclonal antibodies currently used in clinical practice include benralizumab, dupilumab, mepolizumab, omalizumab, reslizumab, and tezepelumab. These agents have demonstrated high efficacy in reducing exacerbation frequency, improving overall disease control, and decreasing the need for systemic corticosteroids. Nevertheless, despite their generally favourable safety profiles, the expanding use of biological therapy in routine clinical practice is uncovering new adverse events that were not previously identified in drug prescribing information. KEYWORDS: severe bronchial asthma, genetically engineered biological therapy, targeted therapy, monoclonal antibodies, type 2 immune response, adverse events, eosinophilia, conjunctivitis, arthralgia, psoriasis, weight gain. FOR CITATION: Titova O.N., Kuzubova N.A., Sklyarova D.B., Afanasyeva Y.A. Adverse events associated with genetically engineered biological agents in patients with severe bronchial asthma: experience in St. Petersburg. Russian Medical Inquiry. 2026;10(8):550–554 (in Russ.). DOI: 10.32364/2587-6821-2026-10-8-4

    2026Russian Medical Inquiry(2026)
    引用
    AI阅读
    加入学术空间
    5Ultrasonography for the Differential Diagnosis of Shock at the Prehospital Stage of Emergency Medical Care
    M. A. Maksimenko, B. N. Shah, V. A. Volchkov, V. N. Lapshin, I. P. Minnullin

    Introduction. The ambulance intensive care medical staff are the first ones who take care of critically ill patients. The diagnosis is often not clear, so treatment may not be optimal, which will lead to a worsening of the patient›s condition. The prehospital diagnostic capabilities of are limited. There is a need for informative, safe, and fast methods of examining critically ill patients. Ultrasound diagnostics seems to be just such a convenient and effective method. The purpose of the work . To evaluate the effect of ultrasonography on the accuracy of diagnosis in patients with different types of shock, developed prehospitally, as well as on the hemodynamic state of patients at the time of their admission to the hospital. Materials and methods . A prospective cohort study was conducted: a comparison was performed between two groups of patients over the age of 18 who were diagnosed with traumatic, hypovolemic, or cardiogenic shock by ambulance intensive care teams. The first group (67 patients) underwent ultrasound with a portable ultrasound scanner using the eFast protocol, followed by measurement of the diameter of the IVC during inhalation and exhalation and calculation of the IVC collapsibility index. The second group (97 patients) was a control group, without performing ultrasound. The following parameters were analyzed for both groups: the dynamics of blood pressure, pulse, and the Algover index, the volume of infusion, the total time of prehospital (ambulance) care, and difference in the diagnoses of the ambulance and the hospital. Results and discussion. In patients with traumatic shock, the diagnosis was correctly established in 90% of cases, in the control group — i n 77% of cases. In patients with hypovolemic shock, the diagnosis was correctly established in 91%, in the control group — in 85%. There were no differences in diagnostic accuracy between the groups for cardiogenic shock. In patients of the first group with signs of traumatic and hypovolemic shocks, a statistically significant increase in systolic and mean blood pressure, a decrease in heart rate and the Algover index were detected after prehospital treatment. The volume of intravenous infusion in the first group was also significantly higher. The ultrasound did not affect the duration of prehospital medical care. Conclusion . Emergency ultrasound performed on ambulance for patients in a state of traumatic and hypovolemic shock is appeared to be an informative method that affects the therapeutic tactics of the ambulance intensive care teams. It is associated with higher hemodynamic parameters of patients admitting to the hospital after prehospital therapy. It leads to a statistically significant decrease in the differences in diagnoses of the ambulance and hospital.

    2026EMERGENCY MEDICAL CARE(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3495 篇论文

    合作机构(100)

    圣彼得堡大学合作论文 241
    俄罗斯科学院合作论文 151
    Saint Petersburg State Pediatric Medical University合作论文 142
    Federal Almazov North-West Medical Research Centre合作论文 133
    Kirov Military Medical Academy合作论文 71
    Sechenov University合作论文 62
    波士顿大学合作论文 47
    俄罗斯联邦卫生部合作论文 44
    圣光机大学合作论文 36
    Pirogov Russian National Research Medical University,Ministry of Health合作论文 29

    机构统计